1 year on.
$15m pa for only Europe from this generic manufacturer.
Drug to be granted approval this fiscal year. Only 2 weeks left.
Was the drug approved? Sec requires UNS to notify us either way.
Where's the initial payments? Did it show as revenue?
Is this deal even included in the $1b pipeline?
I think this needs some deep analysis.
- Forums
- ASX - By Stock
- UNS
- hopefully the first of many
hopefully the first of many, page-41
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)